Lancet Infectious Diseases Explores ART in Low-, Middle-Income CountriesOctober 9, 2009 "As a result of the scale-up of antiretroviral treatment (ART) programmes and substantial financial support worldwide, an increasing number of HIV-infected individuals in low-income and middle-income countries (LIMCs) now have access to ART," write the authors of a Lancet Infectious Diseases review article that explores the current issues faced by those attempting to manage the epidemic in low- and middle-income countries. The review includes information about when to start treatment as well as first- and second-line regimens (Bartlett/Shao, 10/2009). Back to other news for October 2009
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report.
|